Beginning on 1 March 2024, South Australian pharmacists can provide antibiotic treatment without a prescription from a prescriber for uncomplicated urinary tract infections (UTIs) to
Tasmanian pharmacists may be aware of the Tasmanian Community Pharmacy Program, scheduled to go live on 1 March 2024. Endorsed pharmacists practising in approved premises
Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to
In recent years, the pharmacy profession has seen significant expansion in the range of medicines that pharmacists can administer by injection. The scope has broadened
Disclaimer: This article was published in 2023 and reflects the information available at that time. The introduction of electronic prescriptions has improved patient accessibility
Disclaimer: This article was published in 2023 and reflects the information available at that time. Psychostimulant changes The PDL Professional Officers would like to
Disclaimer: This article was published in 2023 and reflects the information available at that time. With the availability of the latest Pfizer (COMIRNATY®) Omicron
Disclaimer: This article was published in 2023 and reflects the information available at that time. Meridian Lawyers has collaborated with PDL to prepare an
Disclaimer: This article was published in 2023 and reflects the information available at that time. Every year, PDL receives calls from pharmacists who have
Disclaimer: This article was published in 2023 and reflects the information available at that time. The prescribing and supply of medicinal cannabis is a
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.